Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for Platinum-resistant Ovarian Cancer
Drug: Bevacizumab
31 locations incl. Mobile
Sponsor: Genelux Corporation
Sex: Female·Age: 18+
Code: NCT05281471·Phase 3·Recruiting